Imagion Biosystems has achieved a key milestone in its progress to first-in-human testing with the commencement of a toxicology safety study of its lead nanoparticle
Imagion Biosystems has updated investors by lodging the latest version of its corporate presentation visuals with the Australian Securities Exchange. Content includes overviews of MagSense®
At the April 2017 Annual Meeting of the American Association for Cancer Research, we first reported our long-circulating mPEG-coated PrecisionMRX® superparamagnetic nanoparticles. Since then, we’ve refined
This year’s Tech Connect World Innovation Conference featured the poster “Superparamagnetic relaxometry (SPMR) for sensitive detection of HER-2 positive tumors in mice” presented by Imagion
Imagion Biosystems (IBX) is an innovative medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases.
Stay informed about our latest news and developments.
© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance